A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
The division cycle of eukaryotic cells is regulated by a family of protein kinases known as the cyclin-dependent kinases (CDKs). The sequential activation of individual members of this family and their consequent phosphorylation of critical substrates promotes orderly progression through the cell cycle. The complexes formed by CDK4 and the D-type cyclins have been strongly implicated in the control of cell proliferation during the G1 phase. CDK4 exists, in part, as a multi-protein complex with a D-type cyclin, proliferating cell nuclear antigen and a protein, p21 (refs 7-9). CDK4 associates separately with a protein of M(r) 16K, particularly in cells lacking a functional retinoblastoma protein. Here we report the isolation of a human p16 complementary DNA and demonstrate that p16 binds to CDK4 and inhibits the catalytic activity of the CDK4/cyclin D enzymes. p16 seems to act in a regulatory feedback circuit with CDK4, D-type cyclins and retinoblastoma protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p16, on the other hand, acts through the Retinoblastoma (Rb) pathway (Serrano et al, 1993).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Serrano et al, 1993
In the citing paper
“p16INK4A is a 16 KDa protein that directly binds to CDK4/6 and blocks the formation of cyclinD-CDK4/6 complexes, thereby preventing phosphorylation of RB and promoting expression of E2F target genes (Serrano et al., 1993).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Serrano et al., 1993
In the citing paper
“This member of the INK4a family is a cyclin D-dependent kinase CDK4 and CDK6 inhibitor, which prevents the phosphorylation of the retinoblastoma protein (Rb), therefore leading to suspension of the cell cycle before the S-phase [78,79].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [78]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
In the citing paper
“Currently, p16Ink4a is one of the widely used markers for studying cellular senescence, and it plays a prominent role in inhibiting CDK4/6 and restricting the progression of G1 to S phase in the cell cycle.16,17”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [16]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
A novel genetic system to detect protein–protein interactions
Fields, S., & Song, O.-K. (1989) · Nature · doi:10.1038/340245a0 · Cited by 6,114
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationSherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationFunctional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
A family of human cdc2-related protein kinases.
Meyerson, M., Enders, G. H., Wu, C. L., Su, L. K., Gorka, C., Nelson, C., Harlow, E., & Tsai, L. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 923
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Research works printed but not linked: 2
- Motokura, T. & Arnold, A. Biochim. biophys. Acta 1155, 63–78 (1993).
- Lukas, J., Pagano, M., Staskova, Z., Draetta, G. & Bartek, J. Oncogene (in the press).
Cited by
Items 501–600 of 1,022
Modulation of p27Kip1 levels by the cyclin encoded by Kaposi's sarcoma‐associated herpesvirus
Mann, D. J., Child, E. S., Swanton, C., Laman, H., & Jones, N. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.654 · Cited by 157
“…cyclin–cdk complexes, p16Ink4a inhibiting the cdks associated with the D-type cyclins (that is, cdk4 and cdk6) and p27Kip1 inhibiting both cyclin D- and cyclin E-dependent activities (Serrano et al., 1993; Kato et al., 1994; Polyak et al., 1994; Toyoshima and Hunter, 1994; Lukas et al., 1995).”
BackgroundGene amplification in human gliomas
Collins, V. P. (1995) · Glia · doi:10.1002/glia.440150309 · Cited by 149
Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs
Yuan, K., Wang, X., Dong, H., Min, W., Hao, H., & Yang, P. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.001 · Cited by 156
Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D. C., & Fountain, J. W. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199806)22:2<157::aid-gcc11>3.0.co;2-n · Cited by 161
Garkavtsev, I., & Riabowol, K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2014 · Cited by 148
“Experiments in which p16 was ectopically expressed suggest a mechanism by which members of the p16 family might inhibit cell growth by inhibiting the activity of CDK4 and CDK6 kinases through formation of p16-CDK complexes that are inactive as kinases and therefore unable to phosphorylate Rb (24).”
BackgroundTakeuchi, S., Bartram, C., Seriu, T., Cw, M., Tobler, A., Janssen, J. W. G., Reiter, A., Ludwig, W., Zimmermann, M., & Schwaller, J. (1995) · Blood · doi:10.1182/blood.v86.2.755.bloodjournal862755 · Cited by 156
Molecular Biology of Head and Neck Cancer
Lam, D. K., & Schmidt, B. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-2527-6.00010-4 · Cited by 155
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 160
Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control
Oelgeschläger, T. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10058 · Cited by 169
“The tumour suppressor gene product p16INK4A has been shown to bind directly to CDK4 and to inhibit CDK4-mediated pRB phosphorylation (Serrano et al., 1993).”
BackgroundPromoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden, P. A., Metzelaar-Blok, J. A. W., Bergman, W., Monique, H., Hurks, H. M. H., Frants, R. R., Gruis, N. A., & Jager, M. J. (2001) · PubMed · Cited by 168
Zhang, S., Ramsay, E. S., & Mock, B. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2429 · Cited by 147
Glioblastoma Multiforme Oncogenomics and Signaling Pathways
Kanu, O. O., Hughes, B., Di, C., Lin, N., Fu, J., Bigner, D. D., Yan, H., & Adamson, C. (2009) · Clinical medicine. Oncology · doi:10.4137/cmo.s1008 · Cited by 146
Requirements for Cell Cycle Arrest by p16INK4a
Bruce, J. L., Hurford, R. K., Classon, M., Koh, J., & Dyson, N. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00072-1 · Cited by 157
Batova, A., Diccianni, M. B., Yu, J., Nobori, T., Link, M. P., Pullen, J., & Yu, A. L.-T. (1997) · PubMed · Cited by 164
Overexpression of cyclin D2 in chronic B-cell malignancies
Delmer, A. J., Cymbalista, F., Tang, R., Ramond, S., Faussat, A., Marie, J., & Zittoun, R. (1995) · Blood · doi:10.1182/blood.v85.10.2870.bloodjournal85102870 · Cited by 159
Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
Inoue, K., Roussel, M. F., & Sherr, C. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3993 · Cited by 144
Puntervoll, H. E., Yang, X. R., Høberg‐Vetti, H., Bachmann, I. M., Avril, M.-F., Benfodda, M., Catricalà, C., Dalle, S., Duval‐Modeste, A. B., Ghiorzo, P., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101455 · Cited by 155
Splicing into Senescence: The Curious Case of p16 and p19ARF
Haber, D. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80441-9 · Cited by 158
“Adjacent to p16 lies the gene encoding one of direct role in cellular immortalization and tumorigenesisits homologs, p15 (also known as INK4b), which demonis now challenged by the experiments of Kamijo andstrates comparable binding and inhibition of CDK4 and coworkers, who suggest that the knockout phenotype CDK6 acti…”
BackgroundInfluentialCyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß
Ravitz, M. J., & Wenner, C. E. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60099-8 · Cited by 168
Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling, M. H., Bullinger, L., Ott, G., Stilgenbauer, S., Müller-Hermelink, H. K., Bentz, M., Hiddemann, W., & Döhner, H. (1997) · PubMed · Cited by 144
Santos, M., Montagut, C. O., Mellado, B., García, Á., y Cajal, S. R., Cardesa, A., Puig-Tintoré, L. M., & Ordï, J. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000130108.03231.89 · Cited by 143
Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142
Collateral lethality: a new therapeutic strategy in oncology
Muller, F. L., Aquilanti, E. A., & DePinho, R. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.10.002 · Cited by 132
“Analysis of the minimal common deleted area led to the discovery of the cell cycle regulators (p16INK4A and p15INK4B) and the tumor suppressor (ARF) which are encoded by the CDKN2A/B locus [35].”
BackgroundSmith, J. C., & Sheltzer, J. M. (2018) · eLife · doi:10.7554/elife.39217 · Cited by 141
Lu, V. M., O’Connor, K. P., Shah, A. H., Eichberg, D. G., Luther, E., Komotar, R. J., & Ivan, M. E. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03528-2 · Cited by 157
“The p14ARF induces cell cycle arrest via interacting with MDM2 and stabilizing p53, interfering with cell repair and apoptosis mechanisms [26, 27].”
BackgroundThe INK4 Family of CDK Inhibitors
Carnero, A., & Hannon, G. J. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_3 · Cited by 187
Self-citationWhen dormancy fuels tumour relapse
Santos-de-Frutos, K., & Djouder, N. (2021) · Communications Biology · doi:10.1038/s42003-021-02257-0 · Cited by 165
Germline Mutations of the CDKN2 Gene in UK Melanoma Families
Harland, M., Meloni, R., Gruis, N., Pinney, E., Brookes, S., Spurr, N. K., Frischauf, A.-M., Bataille, V., Peters, G., Cuzick, J., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2061 · Cited by 142
Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinases
Abraham, R., Acquarone, M., Andersen, A., Asensi, A., Bellé, R., Berger, F., Bergounioux, C., Brunn, G., Buquet‐Fagot, C., Fagot, D., et al. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)81298-6 · Cited by 140
Chromosomal Abnormalities Subdivide Ependymal Tumors into Clinically Relevant Groups
Hirose, Y., Aldape, K., Bollen, A. W., James, C. D., Brat, D. J., Lamborn, K. R., Berger, M. S., & Feuerstein, B. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64061-8 · Cited by 140
Han, E. K.-H., Begemann, M., Sgambato, A., Soh, J. W., Doki, Y., Xing, W. Q., Liu, W., & Weinstein, I. B. (1996) · PubMed · Cited by 158
Lozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
Self-citationMolecular Pathogenesis of Cutaneous Melanocytic Neoplasms
Ibrahim, N., & Haluska, F. G. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151541 · Cited by 138
Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation
Zeng, H., Jorapur, A., Shain, A. H., Lang, U. E., Torres, R., Zhang, Y., McNeal, A. S., Botton, T., Lin, J., Donne, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.014 · Cited by 137
“To confirm whether the induction of BRN2 expression by the CDK4/6-RB1-E2F1 pathway can be observed during the progression of melanoma, we performed co-immunofluorescence visualization of S807/811 phosphorylated RB1 and BRN2.”
BackgroundInfluentialNagpal, J. K., & Das, B. R. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00162-8 · Cited by 168
“The inhibition of the cyclin D1–cdk 4/6 complex activity prevents retinoblastoma phosphorylation leading to the inhibition of the cell cycle G1/S transition [78].”
BackgroundInfluentialCrystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
Lu, H., Chang, D. J., Baratte, B., Meijer, L., & Schulze-Gahmen, U. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049353p · Cited by 147
p19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
Radfar, A., Unnikrishnan, I., Lee, H.-W., DePinho, R. A., & Rosenberg, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13194 · Cited by 138
Racial differences in the expression of cell cycle–regulatory proteins in breast carcinoma
Porter, P. L., Lund, M. J., Lin, M. G., Yuan, X., Liff, J. M., Flagg, E. W., Coates, R. J., & Eley, J. W. (2004) · Cancer · doi:10.1002/cncr.20279 · Cited by 137
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
Arendt, T., Holzer, M., & Gärtner, U. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050104 · Cited by 137
Genetic Alterations in Esophageal Cancer
Kuwano, H., Kato, H., Miyazaki, T., Fukuchi, M., Masuda, N., Nakajima, M., Fukai, Y., Sohda, M., Kimura, H., & Faried, A. (2004) · Surgery Today · doi:10.1007/s00595-004-2885-3 · Cited by 140
p16 gene alterations in nasopharyngeal carcinoma.
Lo, K. W., Huang, D. P., & Lau, K. (1995) · PubMed · Cited by 149
Skapek, S. X., Rhee, J., Kim, P. S., Novitch, B. G., & Lassar, A. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7043 · Cited by 137
“Cyclin-dependent regulation of muscle gene expression in mitogen-stimulated myoblasts seems to be biologically relevant because forced expression of a combination of cdk inhibitors, p16 (64) and p21 (12, 19, 25, 52, 77), in nearly confluent, mitogen-stimulated myoblasts facilitates muscle differentiation in the absenc…”
BackgroundOrigins of G1 arrest in senescent human fibroblasts
Stein, G. H., & Dulić, V. (1995) · BioEssays · doi:10.1002/bies.950170610 · Cited by 135
Melanoma: Molecular pathogenesis and emerging target therapies (Review)
Libra (2009) · International Journal of Oncology · doi:10.3892/ijo_00000277 · Cited by 136
“p16INK4a stops cell cycle inhibiting the cyclin D/CDK4 complex, thereby preventing it from phosphorylating Rb (80).”
New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy
Bury, M., Calvé, B. L., Ferbeyre, G., Blank, V., & Lessard, F. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.01.010 · Cited by 144
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 169
Current review on squamous intraepithelial lesions of the larynx
Gale, N., Michaels, L., Luzar, B., Poljak, M., Zidar, N., Fischinger, J., & Cardesa, A. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03111.x · Cited by 135
Bigos, K. J. A., Quiles, C. G., Lunj, S., Smith, D. J., Krause, M., Troost, E. G. C., West, C., Hoskin, P., & Choudhury, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1331355 · Cited by 166
Cdc37 is required for association of the protein kinase Cdc28 with G1 and mitotic cyclins.
Gerber, M. R., Farrell, A., Deshaies, R. J., Herskowitz, I., & Morgan, D. O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4651 · Cited by 135
Identifying specific functional roles for senescence across cell types
(2024) · doi:10.1016/j.cell.2024.09.021 · Cited by 139
Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis
Martini, M., Ciccarone, M., Garganese, G., Maggiore, C., Evangelista, A., Rahimi, S., Zannoni, G., Vittori, G., & Larocca, L. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10715 · Cited by 135
Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
Ho, K. C., Zhou, Z., She, Y.-M., Chun, A., Cyr, T. D., & Yang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101273108 · Cited by 134
Thunnissen, E., Borczuk, A., Flieder, D. B., Lissenberg-Witte, B. I., Beasley, M. B., Chung, J.-H., Đačić, S., Lantuéjoul, S., Russell, P. A., den Bakker, M., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.12.004 · Cited by 133
Harada, H., Nakagawa, K., Iwata, S., Saito, M., Kumon, Y., Sakaki, S., Sato, K., & Hamada, K. (1999) · PubMed · Cited by 149
Methylation and colorectal cancer
Jubb, A. M., Bell, S. M., & Quirke, P. (2001) · The Journal of Pathology · doi:10.1002/path.923 · Cited by 142
“[153] and was later identified as the putative target of LOH on chromosome 9p [154].”
BackgroundDeletions of the INK4A Gene in Superficial Bladder Tumors
Orlow, I., LaRue, H., Osman, I., Lacombe, L., Moore, L., Rabbani, F., Meyer, F., Fradet, Y., & Cordon‐Cardo, C. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65105-x · Cited by 147
p16 gene homozygous deletions in acute lymphoblastic leukemia
Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J., Bauters, F., Wattel, E., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.3.657.bloodjournal853657 · Cited by 133
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
Silva, J. M., Dominguez, G., Villanueva, M. J., Gonzalez, R., Garcia, J. M., Corbacho, C., Provencio, M., España, P., & Bonilla, F. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690495 · Cited by 132
Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a
Low, K. G., Dorner, L. F., Fernando, D. B., Grossman, J., Jeang, K. T., & Comb, M. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1956-1962.1997 · Cited by 132
“Interestingly, Tax has previously been demonstrated to interact specifically with the ankyrin motifs of IkBg (14) and a three-amino-acid residue AARmotif on CREB (1) which is also present in p16 (35).”
BackgroundYang, Z., Oemar, B. S., Carrel, T., Kipfer, B., Julmy, F., & Lüscher, T. F. (1998) · Circulation · doi:10.1161/01.cir.97.2.181 · Cited by 145
Mechanisms Involved in Ultraviolet Light-Induced Immunosuppression
Beissert, S., & Schwarz, T. (1999) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/sj.jidsp.5640183 · Cited by 142
Iwamoto, T., Hiraku, Y., Oikawa, S., Mizutani, H., Kojima, M., & Kawanishi, S. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03231.x · Cited by 131
Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
Guo, S.-X., Taki, T., Ohnishi, H., Piao, H., Tabuchi, K., Bessho, F., Hanada, R., Yanagisawa, M., & Hayashi, Y. (2000) · Leukemia Research · doi:10.1016/s0145-2126(99)00158-7 · Cited by 137
“hibitors of the cyclin D-CDK4/6 complexes [1–4].”
Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth
Landen, J. W., Hau, V. S., Wang, M., Davis, T. P., Ciliax, B. J., Wainer, B. H., Meir, E. G. V., Glass, J. D., Joshi, H. C., & Archer, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0360 · Cited by 130
INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy
Zindy, F., van Deursen, J., Grosveld, G., Sherr, C. J., & Roussel, M. F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.372-378.2000 · Cited by 130
“In humans, p16, the founding member of the family (42), functions as”
BackgroundAlexandrow, M. G., Kawabata, M., Aakre, M., & Moses, H. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3239 · Cited by 130
Miao, D., Su, H., He, B., Jianjun, G., Xia, Q., Zhu, M., Gu, Z., Goltzman, D., & Karaplis, A. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805690105 · Cited by 132
“Cell-cycle progression PTHrP (1-139) PTHrP (1-84)”
BackgroundAlterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas
Serrano, J., Goebel, S. U., Peghini, P. L., Lubensky, I. A., Gibril, F., & Jensen, R. T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4146 · Cited by 138
Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma.
El‐Naggar, A. K., Lai, S., Clayman, G. L., Lee, J. K., Luna, M. A., Goepfert, H., & Batsakis, J. G. (1997) · Europe PMC (PubMed Central) · Cited by 129
Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.
Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Müller, R., Ansorge, W. J., & Eilers, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00669.x · Cited by 144
Yasui, W., Kudo, Y., Semba, S., Yokozaki, H., & Tahara, E. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00428.x · Cited by 139
Franklin, D. S., & Xiong, Y. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.10.1587 · Cited by 128
Differential Regulation of P27Kip1 Expression by Mitogenic and Hypertrophic Factors
Servant, M. J., Coulombe, P., Turgeon, B., & Meloche, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.3.543 · Cited by 146
“…specifically interacts with Cdk4 and Cdk6 to prevent cyclin D-Cdk assembly or enters into stable ternary complexes with cyclin D-Cdk, resulting in complexes that are catalytically inactive (Serrano et al., 1993; Guan et al., 1994; Hannon and Beach, 1994; Chan et al., 1995; Hirai et al., 1995).”
BackgroundOvercoming Cancer Drug Resistance Utilizing PROTAC Technology
Burke, M. R., Smith, A. R., & Zheng, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.872729 · Cited by 134
Lookeren Campagne, M. V., & Gill, R. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980727)397:2<181::aid-cne3>3.0.co;2-x · Cited by 127
Al-Douahji, M., Brugarolas, J., Brown, P. A., Stehman‐Breen, C. O., Alpers, C. E., & Shankland, S. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00728.x · Cited by 135
A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy
Mazumder, S., DuPree, E., & Almasan, A. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481669 · Cited by 148
“The activity of these CDKs is regulated positively by cyclins and negatively by binding of CDK inhibitors (CKIs) [6,7].”
BackgroundAdenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells
Yang, C.-T., You, L., Yeh, C.-C., Chang, J. W.-C., Zhang, F., McCormick, F., & Jablons, D. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.636 · Cited by 126
Acute renal failure during sepsis: Potential role of cell cycle regulation
Yang, Q.-H., Liu, D., Long, Y., Liu, H.-Z., Chai, W., & Wang, X. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.04.003 · Cited by 126
Malignant Peripheral Nerve Sheath Tumor
Zhou, H., Coffin, C. M., Perkins, S. L., Tripp, S. R., Liew, M. A., & Viskochil, D. H. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00006 · Cited by 125
“inhibits the function of the cell cyclin kinase CDK4- and CDK6-cyclin D complexes, thus controlling cell proliferation through the retinoblastoma (pRB) pathway.(26,31,45) Inactivation of CDKN2A/p16 has been observed in a wide variety of human tumors, including MPNST.”
BackgroundCudejko, C., Wouters, K., Fuentes, L., Hannou, S. A., Paquet, C., Bantubungi, K., Bouchaert, E., Vanhoutte, J., Fleury, S., Remy, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313106 · Cited by 125
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El-Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 126
“p16 is a specific inhibitor of the closely related cyclin-dependent kinases (cdk’s) 4 and 6 (96, 109).”
BackgroundmTOR Signaling from Cellular Senescence to Organismal Aging
Xu, S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500263 · Cited by 124
“…disappearance of the epidermal stem cell compartment and subsequent hair loss [54] Senescence programs also engage another important signaling pathway, the p16-pRb pathway (Figure 1). p16 is a cell cycle factor that functions as an inhibitor of cyclin-dependent kinases Cdk4 and Cdk6 [5, 6, 31].”
Dissenting degradation: Deubiquitinases in cell cycle and cancer
Bonacci, T., & Emanuele, M. J. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.008 · Cited by 136
Sumoylation induced by the Arf tumor suppressor: A p53-independent function
Tago, K., Chiocca, S., & Sherr, C. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502978102 · Cited by 147
The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
Lee, M. H., Nikolic, M., Baptista, C. A., Lai, E., Tsai, L. H., & Massagué, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3259 · Cited by 124
Sacks, P. G. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00049486 · Cited by 129
Demenais, F., Mohamdi, H., Chaudru, V., Goldstein, A. M., Newton Bishop, J. A., Bishop, D. T., Kanetsky, P. A., Hayward, N. K., Gillanders, E., Elder, D. E., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq363 · Cited by 123
“This protein is known to inhibit the cyclindependent kinase 4 (CDK4)–mediated phosphorylation of retinoblastoma 1 protein and prevents the cell from progressing through the G1 cell cycle checkpoint (3,4).”
BackgroundSviderskaya, E. V., Gray-Schopfer, V. C., Hill, S. P., Smit, N. P., Evans-Whipp, T. J., Bond, J., Hill, L., Bataille, V., Peters, G., Kipling, D., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.10.723 · Cited by 123
Mechanisms of T-Cell Activation by Human T-Cell Lymphotropic Virus Type I
Höllsberg, P. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.308-333.1999 · Cited by 144
“It remains to be determined whether Tax also inhibits p15, a mediator of TGF-b inhibition, which is 97% homologous to p16 in the last three of its four ankyrin motifs (264).”
BackgroundMammalian anti proliferative signals and their targets
Massagué, J., & Polyák, K. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90059-4 · Cited by 130
Rampias, T., Boutati, E., Pectasides, E., Sasaki, C., Kountourakis, P., Weinberger, P., & Psyrri, A. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0345 · Cited by 105
“434 hypophosphorylated p105 repress the transcription of genes such as cyclin A that are required for cell cycle progression (9).”
BackgroundRoles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Nozaki, M., Tada, M., Kobayashi, H., Zhang, C. L., Sawamura, Y., Abe, H., Ishii, N., & Meir, E. G. V. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.2.124 · Cited by 122
Molecular Pathogenesis of Hepatocellular Carcinoma
Ho, D. W., Lo, R. C., Chan, L., & Ng, I. O. (2016) · Liver Cancer · doi:10.1159/000449340 · Cited by 132
Clément, G., Braunschweig, R., Pasquier, N., Bosman, F. T., & Benhattar, J. (2005) · The Journal of Pathology · doi:10.1002/path.1884 · Cited by 125
“Methylation was not found for CDKN2A.”
BackgroundInfluentialFrequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome
Scarisbrick, J. J., Woolford, A. J. ‐., Calonje, E. J., Photiou, A., Ferreira, S., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01682.x · Cited by 133
Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines
Kawa, S., Nikaido, T., Aoki, Y., Zhai, Y., Kumagai, T., Furihata, K., Fujii, S., & Kiyosawa, K. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.479 · Cited by 121
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 132
Villuendas, R., Sánchez‐Beato, M., Martínez, J. C., Sáez, A. I., Martínez–Delgado, B., García, J. F., Mateo, M. S., Sánchez‐Verde, L., Benitez, J. J., Martínez, P., et al. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65630-1 · Cited by 132
“p16/ INK4A exerts its function by competing with cyclin D in binding to CDK4 and preventing the activation of this kinase.(3,4) It has been demonstrated that p16/INK4A prevents cellular transformation by H-Ras, acting as a tumor suppressor gene.”
BackgroundStability and folding of the tumour suppressor protein p16 1 1Edited by J. Karn
Tang, K. S., Guralnick, B. J., Wang, W. K., Fersht, A. R., & Itzhaki, L. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2420 · Cited by 134
“The original cDNA clone of p16 was N-terminally truncated by eight amino acid residues (Serrano et al., 1993), and later the full-length sequence of 156 residues was discovered (Hannon & Beach, 1994).”
BackgroundInfluential
Metadata
- Authors
- Serrano, M., Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1993-12
- Volume
- 366
- Issue
- 6456
- Pages
- 704-707
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2066848701
- Cited by
- 3,650
- References
- 22
- Citations by year
- 2026: 36 · 2025: 46 · 2024: 52 · 2023: 66 · 2022: 67 · 2021: 78 · 2020: 64 · 2019: 63 · 2018: 56 · 2017: 70 · 2016: 69 · 2015: 75 · 2014: 52 · 2013: 98 · 2012: 88
- FWCI
- 78.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p16, CDK4, cyclin D, cyclin-dependent kinases, cell cycle regulation, G1 phase, kinase inhibition, retinoblastoma protein, p21, proliferating cell nuclear antigen, feedback regulation, cell proliferation
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cloning, Molecular, DNA, Glutathione Transferase, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Saccharomyces cerevisiae, Oncogene Proteins, Retinoblastoma Protein, Cyclins, Cyclin-Dependent Kinases, Cyclin D1, Cyclin-Dependent Kinase Inhibitor p16, Protein Kinase Inhibitors, Cyclin-Dependent Kinase 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.